article thumbnail

Antibody Drug Conjugates: windows of opportunity

Drug Target Review

The drivers behind the demand for ADCs Providing more targeted therapeutic options in the oncology space has underpinned the rapid growth of the ADC market; between 2016 to 2020, the US ADC market grew by 45 percent to a value of nearly $1.5 Petra holds a D.Phil in synthetic organic chemistry and am MBA from Imperial College London.

article thumbnail

Women in Stem with Dr Emily Leproust

Drug Target Review

I started my journey in chemistry – first as an undergraduate and then in my PhD programme at the University of Houston, where I focused on organic chemistry and nucleic acids chemistry. Can you tell us about your journey in the field of STEM and the challenges you encountered along the way?

DNA 116
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Developing the next generation of antibody drug conjugates

Drug Target Review

Despite excellent pharmacokinetic and stable antibody-linker connections, such ADCs have yet to receive market approval. With a passion for organic chemistry, Léo’s expertise lies in the meticulous design and synthesis of compounds crucial to advancing medical science.

article thumbnail

[Panel Webinar] How to tap into pharma’s $100bn digital transformation opportunity

The Pharma Data

Presenters: Dr. Haydn Boehm, Head of Commercial Marketing – Connected Lab at Merck Group. Haydn Boehm is the Head of Commercial Marketing for Merck’s Connected Lab digital program and has over 20 years’ experience in marketing and business development within the life scientific sector.

article thumbnail

Marquis Who’s Who Honors David R. Elmaleh, PhD, with Inclusion in Who’s Who in the World

The Pharma Data

A graduate of the Hebrew University of Jerusalem, he earned a Bachelor of Science in chemistry and physics and a Master of Science in physical organic chemistry before completing a Doctor of Philosophy in 1971.

article thumbnail

Marquis Who’s Who Honors James D. McChesney, PhD, with Inclusion in Who’s Who in the World

The Pharma Data

He continued his education at Indiana University, where he completed a Master of Arts in botany in 1964, and a Doctor of Philosophy in organic chemistry in 1965. He attributes his success to good fortune and hard work, and hopes to see some of his patented compounds gain approval and reach market readiness in the coming years.

Science 52
article thumbnail

Women in Stem with Dr Rachel Lagiakos

Drug Target Review

Coupling my desire to be a scientist with my keen sense of adventure, I moved to Alaska out of high school to begin my undergraduate studies in chemistry, applying myself to my STEM classes whilst also climbing mountains and chasing Northern Lights.